Article
Genetically Predicted Levels of Lipoprotein(a) and Risk of Cerebrovascular Disease.
Journal of the American Heart Association - 3 Feb 2026
Daghlas Iyas, Georgakis Marios K, Arsenault Benoit J, Kim Anthony S, Burgess Stephen, Gill Dipender
Abstract excerpt
BACKGROUND: Lipoprotein(a) (Lp(a)) is a highly atherogenic lipoprotein and the target of investigational therapies. Using a Mendelian randomization study design, we aimed to clarify associations between genetically predicted Lp(a) levels and cerebrovascular disease outcomes and related phenotypes. METHODS: We obtained genetic associations with Lp(a) levels (n=343 681), ischemic stroke subtypes (≤62 100 cases),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
